Shin Nippon Biomedical Laboratories, Ltd.

TSE:2395 Stock Report

Market Cap: JP¥54.5b

Shin Nippon Biomedical Laboratories Management

Management criteria checks 2/4

Shin Nippon Biomedical Laboratories' CEO is Ryoichi Nagata, appointed in Jan 1991, has a tenure of 33.5 years. directly owns 2.46% of the company’s shares, worth ¥1.34B. The average tenure of the management team and the board of directors is 2.1 years and 9.1 years respectively.

Key information

Ryoichi Nagata

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure33.5yrs
CEO ownership2.5%
Management average tenure2.1yrs
Board average tenure9.1yrs

Recent management updates

Recent updates

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Jul 12
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 21
Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 10
Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Mar 12
Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

Feb 27
Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

CEO

Ryoichi Nagata (66 yo)

33.5yrs

Tenure

JP¥144,061,000

Compensation

Dr. Ryoichi Nagata, M.D., Ph D., F.F.P.M., serves as President & Director of Satsuma Pharmaceuticals, Inc. since June 8, 2023 Also serves as it's Chief Executive Officer and Group Financial Officer since 2...


Leadership Team

NamePositionTenureCompensationOwnership
Ryoichi Nagata
President33.5yrsJP¥144.06m2.46%
¥ 1.3b
Fumihiko Makino
Senior Executive Officer2.5yrsno datano data
Toshiyuki Iwata
Managing Executive Officer and GM of IR Public Relations Department & Sustainability1.5yrsno datano data
Shinji Nitanda
Senior MD of Corporate Development & Corporate Tax Administration and Director2.1yrsno datano data
Kyomi Nagatoshi
Senior Managing Executive Officerno datano datano data
Ken Takanashi
Executive VP of Group Corporate Management & Global Business & Director20.1yrsno data0.088%
¥ 48.0m
Satoshi Matsumoto
Managing Executive Officer & GM of Fisheries Divisionless than a yearno datano data
Hideshi Tsusaki
Senior MD1.5yrsno datano data
Terumasa Hirai
Managing Executive Officerno datano datano data
Eishi Tsunozaki
Senior MD & Directorno datano data0.043%
¥ 23.7m
Ichiro Nagata
Executive VPno datano data40.33%
¥ 22.0b
Takashi Iriyama
Senior Managing Executive Officerno datano datano data

2.1yrs

Average Tenure

57yo

Average Age

Experienced Management: 2395's management team is considered experienced (2.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ryoichi Nagata
President41.3yrsJP¥144.06m2.46%
¥ 1.3b
Shinji Nitanda
Senior MD of Corporate Development & Corporate Tax Administration and Director14.1yrsno datano data
Kyomi Nagatoshi
Senior Managing Executive Officerno datano datano data
Ken Takanashi
Executive VP of Group Corporate Management & Global Business & Director21.6yrsno data0.088%
¥ 48.0m
Hideshi Tsusaki
Senior MD10.1yrsno datano data
Eishi Tsunozaki
Senior MD & Director10.1yrsno data0.043%
¥ 23.7m
Ichiro Nagata
Executive VP4.1yrsno data40.33%
¥ 22.0b
Shinichi Fukumoto
Independent Outside Director9.1yrsno datano data
Takashi Yamashita
Independent Outside Director9.1yrsno datano data
Masakazu Suda
Full-Time Auditor4.1yrsno data0.015%
¥ 8.2m
Tsuyoshi Hanada
Independent Outside Director4.1yrsno data0.0079%
¥ 4.3m
Keiko Totani
Independent Outside Director3.1yrsno datano data

9.1yrs

Average Tenure

60yo

Average Age

Experienced Board: 2395's board of directors are considered experienced (9.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.